3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycythemia Vera
1
Meningeal Carcinomatosis
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Epstein-Barr Virus Infections
1
Brain Neoplasms
1
Interventions
pembrolizumab
14
Nivolumab
10
Ipilimumab
10
Axitinib
6
cabozantinib
5
belzutifan
5
Radiosurgery
5
atezolizumab
4
Sunitinib
4
palbociclib
3
lenvatinib
3
Surveys and Questionnaires
3
Radiotherapy
3
Pluvicto
3
Everolimus
3
Blood Specimen Collection
3
Biopsy
3
zimberelimab
2
pazopanib
2
cemiplimab
2
Therapeutics
2
Methods
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
trebananib
1
toripalimab
1
tocilizumab
1
temsirolimus
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Interferons
×
1 year
×
Clear all
No trials found.